TRIB

Trinity Biotech

45 hedge funds and large institutions have $78.4M invested in Trinity Biotech in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
-3
Holders Change %
-6.25%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
10
Reduced
12
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
BCA
26
Benchmark Capital Advisors
New York
$118K -$5.4K -210 -4%
US Bancorp
27
US Bancorp
Minnesota
$108K -$83.8K -3,243 -44%
WS
28
Wedbush Securities
California
$93K -$31.5K -1,220 -25%
RC
29
RBF Capital
California
$77K
TRCT
30
Tower Research Capital (TRC)
New York
$51K +$4.31K +168 +9%
WAS
31
WESPAC Advisors SoCal
California
$26K
ECM
32
Engine Capital Management
New York
$22K
Bank of Montreal
33
Bank of Montreal
Ontario, Canada
$17K
JCM
34
Jacobi Capital Management
Pennsylvania
$10K
UBS Group
35
UBS Group
Switzerland
$6K +$4.59K +175 +324%
WT
36
Whittier Trust
California
$5K
AG
37
Advisor Group
Arizona
$5K
RE
38
RBC Europe
United Kingdom
$4.08K
IA
39
IFP Advisors
Florida
$3K
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$3K
Bank of America
41
Bank of America
North Carolina
$3K +$932 +41 +45%
ASN
42
Advisory Services Network
Georgia
$1K
AP
43
Atwood & Palmer
Missouri
$1K
Simplex Trading
44
Simplex Trading
Illinois
$1K +$612 +30 +158%
SKK
45
Shepherd Kaplan Krochuk
Massachusetts
-$186K -7,280 Closed
RJA
46
Raymond James & Associates
Florida
-$74K -2,906 Closed
DCM
47
Delpha Capital Management
New York
-$1K -21 Closed